Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Applied Therapeutics Inc (APLT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Applied Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.230 -0.080    -1.86%
16:00:04 - Closed. Currency in USD ( Disclaimer )
After Hours
4.250
+0.020
+0.473%
19:20:28 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 561,869
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 4.170 - 4.360
Applied Therapeutics 4.230 -0.080 -1.86%

Applied Therapeutics Inc Company Profile

 
Get an in-depth profile of Applied Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

25

Equity Type

ORD

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company’s lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Contact Information

Address 545 Fifth Avenue Suite 1400
New York, 10017
United States
Phone 212 220 9226
Fax -

Top Executives

Name Age Since Title
Lawrence Steinman 76 - Member of Scientific Advisory Board
Gregg W. Stone 67 - Member of Scientific Advisory Board
Teena L. Lerner 66 2017 Lead Independent Director
Donald J. D'Amico - - Member of Scientific Advisory Board
Roy Lester Freeman 71 - Member of Scientific Advisory Board
Shoshana Shendelman 45 2016 Chair of the Board of Directors, Founder, President, CEO & Secretary
Jay S. Skyler 77 2019 Independent Director
Stacy J. Kanter 65 2019 Independent Director
Roxana Mehran - - Member of Scientific Advisory Board
Les D. Funtleyder 53 2016 CFO, Principal Financial Officer & Independent Director
Donald W. Landry 69 - Chairman of Scientific Advisory Board
Joel S. Marcus 77 2017 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

APLT Comments

Write your thoughts about Applied Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Hobbins
Mike Hobbins Jul 30, 2020 10:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It Struggles, to Not hit a new Low. Meanwhile Germany, And Other European Countries PLUMMET 2.5 - 3.5% -Let's See how long it Can Hold out, before Fresh LOW, Like Rest of Martket. Have you Seen the Dow??
Cameron Symonds
Cameron Symonds Jun 23, 2020 8:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think it's time to jump in,this company has a record of lows them a pitch up,it may still go down by a bit tho
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email